Carisma Therapeutics
CARM
CARM
53 hedge funds and large institutions have $84M invested in Carisma Therapeutics in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 9 closing their positions.
Holders
53
Holders Change
+16
Holders Change %
+43.24%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
15
Reduced
6
Closed
9
Calls
$5.49M
Puts
$1.63M
Net Calls
+$3.86M
Net Calls Change
+$2.74M
Top Buyers
1 |
1
BlackRock
New York
|
$15.6M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$13.2M |
3 |
3
State Street
Boston,
Massachusetts
|
$4.17M |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$4.74M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$1.92M |